Point-of-Care Monitoring of Anticoagulation Therapy, 1st Edition
This document provides guidance to users and manufacturers of point-of-care coagulation devices for monitoring heparin and warfarin anticoagulant therapy, and to ensure reliable results comparable to those obtained by routine clinical laboratory testing.
This document is available in electronic format only.
Members: $54.00 → $153.00Nonmembers: $180.00
Chairholder: Bruce H. Davis, MD and Samuel J. Machin, MB, ChB, FRCPath, FRCP
Date of Publication: July 1, 2004
Order Code PDF: POCT14AE
ISBN Number: 1-56238-540-2
Order Code Print: print not available
POCT14 Additional Details
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement.
This document was formerly sold under the code H49.